Global Renal Biomarkers Market Report 2024

Renal Biomarkers Global Market Report 2024 – By Biomarker Type (Functional Biomarker, Up Regulated Protein, Other Biomarker Types), By Diagnostic Technique (Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)), By Application (Diagnosis And Disease Progression Monitoring, Research Homecare), By End User (Hospitals, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Renal Biomarkers Global Market Report 2024

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Renal Biomarkers Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Renal Biomarkers Market Definition And Segments

Renal biomarker refers to proteins, lipids, genes, metabolites, proteomic patterns, or cells that are found on a urinalysis that is employed to determine the glomerular filtration rate of the kidney, a drop in which indicates kidney damage. The renal biomarkers are used to estimate the nature and severity of kidney injury.

The main types of biomarkers in renal biomarkers are functional biomarker, upregulated protein, and other biomarker types. Functional biomarkers refer to the biomarker that allows the diagnosis of kidney injury in individuals with normal kidney function, also in chronic kidney disease patients where the same injury would give rise to a significant decrease in functional biomarkers such as Cr. The different diagnostic techniques include enzyme-linked immunosorbent assay, particle-enhanced turbidimbiometric immunoassay (PETIA), colorimetric assay, and chemiluminescent enzyme immunoassay (CLIA), liquid chromatography-mass spectrometry (LS-MS). The applications include diagnosis and disease progression monitoring and research homecare and are used by hospitals, diagnostic laboratories, and other end users.

The renal biomarkers market covered in this report is segmented –

1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types

2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)

3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare

4) By End User: Hospitals, Diagnostic Laboratories, Other End Users

The renal biomarkers market size has grown strongly in recent years. It will grow from $1.17 billion in 2023 to $1.27 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing prevalence of kidney diseases, advances in medical diagnostics, aging population, growing awareness of early disease detection, adoption of point-of-care testing, rise in chronic diseases.

The renal biomarkers market size is expected to see strong growth in the next few years. It will grow to $1.74 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to personalized medicine and targeted therapies, integration of biomarker testing into routine clinical practice, emerging markets in Asia and Latin America, non-invasive biomarker testing methods, continuous monitoring with wearable devices. Major trends in the forecast period include multiplex biomarker panels for comprehensive disease profiling, ai and machine learning for biomarker discovery, biomarker-based companion diagnostics, poc biomarker testing in home healthcare settings, biomarkers for early detection and prevention.

Rising Demand For Renal Biomarkers Impact Of Geriatric And Pediatric Patients

The rise in geriatric and pediatric renal patients is expected to propel the growth of the renal biomarkers market going forward. Geriatric renal patients refer to the elderly patients aged above 70 years with advanced chronic kidney disease (CKD). However, pediatric renal patients refer to the patients who are commonly diagnosed with renal disorders during childhood and young adulthood. Renal biomarkers help to evaluate the severity of renal injury in geriatric and pediatric renal patients. For instance, in March 2021, according to the data published by the Centers for Disease Control and Prevention, a US-based government administrative agency, nearly 37 million adults in the US have chronic renal disease and it is more prevalent in adults 65 years of age and older (38%). Therefore, the rise in geriatric and pediatric renal patients is driving the growth of the renal biomarkers market.

Rising Chronic Kidney Disease Incidence Fuels Renal Biomarkers Market Growth

Rising incidence of chronic kidney diseases is expected to propel the growth of the renal biomarkers market going forward. Chronic kidney disease (CKD) is a medical condition characterized by the gradual loss of kidney function over time. Renal biomarkers play a crucial role in identifying and tracking the progression of CKD, facilitating timely intervention and personalized treatment strategies, ultimately improving patient outcomes. For instance, in March 2022, according to the Centers for Medicare & Medicaid Services (CMS), the prevalence of CKD had increased over time, from 15% in 2012 to 25% in 2020, and stated that the two main causes of CKD are diabetes and hypertension. Therefore, the rising incidence of chronic kidney diseases is driving the growth of the renal biomarkers market.

Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Eli Lilly and Company, Alere Inc., AstraZeneca PLC, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings PLC, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings PLC, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd ., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc.

Innovative Technologies Transforming The Renal Biomarkers Market

Technological advancements have emerged as a key trend gaining popularity in the renal biomarkers market. Major players operating in the renal biomarkers sector is focused on developing innovative technologies to sustain their position in the market. For instance, In January 2021, RenalytixAI, a UK-based developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, partnered with DaVita to develop KidneyIntelX. KidneyIntelX is a diagnostic tool powered by artificial intelligence to help spot those at risk of renal disease or kidney failure. KidneyIntelX uses a machine-learning algorithm to produce a patient-specific risk assessment based on blood biomarkers and electronic medical information.

Strategic Collaborations To Expand Product Portfolio

Major companies are strategically entering into partnerships and collaborations with start-ups and mid-sized companies in the renal biomarkers market to broaden the products and services offered by the company. Strategic collaborations and partnership agreements help companies expand their existing product portfolio and geographical reach. For instance, in June 2022, Nordic Bioscience, a Denmark based biomarker company, announced the strengthening of its ongoing collaboration with F. Hoffmann-La Roche Ltd., a multinational healthcare company for the development of proprietary biomarkers involved in tissue breakdown and build-up. Under the collaboration, Nordic Bioscience will transfer unique and proprietary blood-based biomarkers to Roche Diagnostics to be implemented on the automated COBAS platform. Nordic Bioscience's (Extracellular Matrix) ECM biomarkers are unique and essential for all chronic diseases involving tissue fibrosis inflammation and kidney diseases. The collaboration will facilitate better clinical decisions in drug development and patient selection as well as enrichment for precision medicine and ultimately improve patient outcomes.

Renalytix AI Partnered With Joslin Diabetes Center

In April 2021, Renalytix AI, a US-based biotechnology research company, partnered with the Joslin Diabetes Center to integrate new biomarkers for chronic kidney disease. Through this partnership, Renalytix can enhance the indicators already being collected by KidneyIntelX with a panel of novel biomarkers. KidneyIntelX evaluates the likelihood of adverse kidney outcomes in people with Type 2 diabetes and early kidney disease. Joslin Diabetes Center is a US-based diabetes research center and diabetes clinic.

North America was the largest region in the renal biomarkers market in 2023. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the renal biomarkers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the renal biomarkers market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The renal biomarker market consists of revenues earned by entities by providing renal biomarker services such as integrated drug discovery, phenotypic assay, custom services, in vivo, biomarker identification, glomerular filtration diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The renal biomarker market also includes sales of point-of-care kits, antibody screening, cell-based diagnostic devices which are used in providing renal biomarker services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The renal biomarker market research report is one of a series of new reports from The Business Research Company that provides renal biomarker market statistics, including renal biomarker industry global market size, regional shares, competitors with a renal biomarker market share, detailed renal biomarker market segments, market trends and opportunities, and any further data you may need to thrive in the renal biomarker industry. This renal biomarker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Renal Biomarkers Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $1.27 billion
Revenue Forecast In 2033 $1.74 billion
Growth Rate CAGR of 8.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types
2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)
3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare
4) By End User: Hospitals, Diagnostic Laboratories, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Abbott Laboratories; BioPorto Diagnostics A/S; Roche Holding AG; Thermo Fisher Scientific; bioMérieux SA; Randox Laboratories; Siemens Healthineers; Beckman Coulter Inc.; Astute Medical Inc.; Nexelis Company; Sphingotec GmbH; Bio-Rad Laboratories India Pvt. Ltd.; Enzo Biochem Inc.; PerkinElmer Inc.; Novartis AG; Eli Lilly and Company; Alere Inc.; AstraZeneca plc; Bio-Techne Corp.; DiaSorin S.p.A.; EKF Diagnostics Holdings plc; Fujirebio Diagnostics Inc.; Gold Standard Diagnostics Corp.; Merck KGaA; Myriad RBM Inc.; Ortho Clinical Diagnostics Holdings plc; Quidel Corporation; R&D Systems Inc.; Roche Diagnostics International Ltd .; Sekisui Chemical Co. Ltd.; Sysmex Corporation; Tosoh Bioscience Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Renal Biomarkers Market Characteristics

    3. Renal Biomarkers Market Trends And Strategies

    4. Renal Biomarkers Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Renal Biomarkers Market Size and Growth

    5.1. Global Renal Biomarkers Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Renal Biomarkers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Renal Biomarkers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Renal Biomarkers Market Segmentation

    6.1. Global Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Functional Biomarker

    Up Regulated Protein

    Other Biomarker Types

    6.2. Global Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Enzyme-Linked Immunosorbent Assay

    Particle-Enhanced Turbidimetric Immunoassay (PETIA)

    Colorimetric Assay

    Chemiluminescent Enzyme Immunoassay (CLIA)

    Liquid Chromatography Mass Spectrometry (LS-MS)

    6.3. Global Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Diagnosis And Disease Progression Monitoring

    Research Homecare

    6.4. Global Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Diagnostic Laboratories

    Other End Users

    7. Renal Biomarkers Market Regional And Country Analysis

    7.1. Global Renal Biomarkers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Renal Biomarkers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Renal Biomarkers Market  

    8.1. Asia-Pacific Renal Biomarkers Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Renal Biomarkers Market  

    9.1. China Renal Biomarkers Market Overview  

    9.2. China Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Renal Biomarkers Market  

    10.1. India Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Renal Biomarkers Market  

    11.1. Japan Renal Biomarkers Market Overview  

    11.2. Japan Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Renal Biomarkers Market  

    12.1. Australia Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Renal Biomarkers Market  

    13.1. Indonesia Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Renal Biomarkers Market  

    14.1. South Korea Renal Biomarkers Market Overview  

    14.2. South Korea Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Renal Biomarkers Market  

    15.1. Western Europe Renal Biomarkers Market Overview

    15.2. Western Europe Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Renal Biomarkers Market  

    16.1. UK Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Renal Biomarkers Market  

    17.1. Germany Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Renal Biomarkers Market  

    18.5. France Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Renal Biomarkers Market  

    19.9. Italy Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Renal Biomarkers Market  

    20.13. Spain Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Renal Biomarkers Market  

    21.1. Eastern Europe Renal Biomarkers Market Overview

    21.2. Eastern Europe Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Renal Biomarkers Market  

    22.1. Russia Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Renal Biomarkers Market  

    23.1. North America Renal Biomarkers Market Overview

    23.2. North America Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Renal Biomarkers Market  

    24.1. USA Renal Biomarkers Market Overview

    24.2. USA Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Renal Biomarkers Market  

    25.1. Canada Renal Biomarkers Market Overview

    25.2. Canada Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Renal Biomarkers Market  

    26.1. South America Renal Biomarkers Market Overview

    26.2. South America Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Renal Biomarkers Market  

    27.1. Brazil Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Renal Biomarkers Market  

    28.1. Middle East Renal Biomarkers Market Overview

    28.2. Middle East Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Renal Biomarkers Market  

    29.1. Africa Renal Biomarkers Market Overview

    29.2. Africa Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Renal Biomarkers Market Competitive Landscape And Company Profiles

    30.1. Renal Biomarkers Market Competitive Landscape

    30.2. Renal Biomarkers Market Company Profiles

    30.2.1. Abbott Laboratories

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. BioPorto Diagnostics A/S

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Roche Holding AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Thermo Fisher Scientific

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. bioMérieux SA

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Renal Biomarkers Market Competitive Benchmarking

    32. Global Renal Biomarkers Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Renal Biomarkers Market

    34. Renal Biomarkers Market Future Outlook and Potential Analysis

    34.1 Renal Biomarkers Market In 2028 - Countries Offering Most New Opportunities

    34.2 Renal Biomarkers Market In 2028 - Segments Offering Most New Opportunities

    34.3 Renal Biomarkers Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Renal Biomarkers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Renal Biomarkers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Abbott Laboratories Financial Performance
  • Table 76: BioPorto Diagnostics A/S Financial Performance
  • Table 77: Roche Holding AG Financial Performance
  • Table 78: Thermo Fisher Scientific Financial Performance
  • Table 79: bioMérieux SA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Renal Biomarkers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Renal Biomarkers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Abbott Laboratories Financial Performance
  • Figure 76: BioPorto Diagnostics A/S Financial Performance
  • Figure 77: Roche Holding AG Financial Performance
  • Figure 78: Thermo Fisher Scientific Financial Performance
  • Figure 79: bioMérieux SA Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the red winemarket?

Red wine is a wine with a primarily red color that results from the natural pigment found in the peels of dark-colored grapes during fermentation. The alcohol content of red wine is typically between 12 -15%. Antioxidants abound in red wine, and moderate consumption is good for health. For further insights on the red wine market, request a sample here

How will the red wine market drivers and restraints affect the red wine market dynamics? What forces will shape the red wine industry going forward?

The red wine market major growth driver - rising health awareness fuels growth in the red wine market. For further insights on the red wine market, request a sample here

What is the forecast market size or the forecast market value of the red wine market ?

The red wine market size has grown steadily in recent years. It will grow from $106.52 billion in 2023 to $111.84 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to cultural and tradition, growth of wine tourism, evolving consumer preferences, growing popularity of wine as a social drink, wine's association with health benefits. The red wine market size is expected to see strong growth in the next few years. It will grow to $136.77 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to rising disposable income and greater urbanization, increasing proportion of millennials, changing consumer preferences and acceptance of alcoholic beverages, shifting global demand and climate change, growth of online sales and direct-to-consumer channels . Major trends in the forecast period include premiumization of wine, natural and minimalist winemaking, technology and wine apps, wine and food pairing, alternative packaging. For further insights on the red wine market, request a sample here

How is the red wine market segmented?

The red wine market is segmented
1) By Type: Sparkling Red Wine, Still Red Wine
2) By Packaging Type: Bottles, Cans
3) By Distribution Channel: Food Service, RetailFor further insights on the red wine market,
request a sample here

Which region has the largest share of the red wine market? What are the other regions covered in the report?

North America was the largest region in the red wine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the red wine market share during the forecast period. The regions covered in the red wine market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the red wine market, request a sample here.

Who are the major players in the red wine market?

Major companies operating in the red wine market include Accolade Wines, Caviro S.C.A., Vina Concha Y Toro S.A., Castel Winery PLC, E. & J. Gallo Winery, Grupo Peñaflor S.A., Diageo plc, Treasury Wine Estates Limited, Constellation Brands Inc., The Wine Group Inc., Campari Group, Brown-Forman Corporation, Amvyx SA, Rémy Cointreau SA, Compagnia Del Vino SRL, Pernod Ricard SA, Trinchero Family Estates, Bronco Wine Company, Vintage Wine Estates, Ste. Michelle Wine Estates, Kendall-Jackson Vineyard Estates, Bodegas Torres, Concha y Toro, Antinori S.p.A., Opus One, Silver Oak Cellars, Caymus Vineyards, Robert Mondavi Winery For further insights on the red wine market, request a sample here.

What are the key trends in the red wine market?

Major trend in the red wine market - rising demand for organic products shapes the red wine market. For further insights on the red wine market, request a sample here.

What are the major opportunities in the red wine market? What are the strategies for the red wine market?

For detailed insights on the major opportunities and strategies in the red wine market, request a sample here.

How does the red wine market relate to the overall economy and other similar markets?

For detailed insights on red wine market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the red wine industry?

For detailed insights on the mergers and acquisitions in the red wine industry, request a sample here.

What are the key dynamics influencing the red wine market growth? SWOT analysis of the red wine market.

For detailed insights on the key dynamics influencing the red wine market growth and SWOT analysis of the red wine industry, request a sample here.